Major adverse cardiovascular events and mortality with opioids versus NSAIDs initiation in patients with rheumatoid arthritis
In this medfyle
Pain is a common problem in RA, and opioids are commonly used. But in addition to their known addiction and overdose risks, opioids can increase proinflammatory cytokines, and may represent a CVD risk. This study set out to compare MACE and death with opioids versus NSAID.
This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.
Expert commentary
About this Medfyle
©2023 Medfyle. All rights reserved.
Original article:
Ozen G, Pedro S, Michaud K. Major adverse cardiovascular events and mortality with opioids versus NSAIDs initiation in patients with rheumatoid arthritis. Ann Rheum Dis. 2023 Nov;82(11):1487-1494. doi: 10.1136/ard-2023-224339. Epub 2023 Jul 17. PMID: 37460169.
The authors of the original article and the publisher were not involved in the creation of the summary.
